BHC
Bausch Health Companies Inc
NYSE: BHC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.68
+3.54% today
Updated 2026-07-29
Market cap
$1.80B
P/E ratio
—
P/S ratio
0.17x
EPS (TTM)
$-3.24
Dividend yield
—
52W range
$5 – $9
Volume
2.3M
Bausch Health Companies Inc (BHC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$4.68
12-Month target
$5.67
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $8.4B | $8.1B | $8.8B | $9.6B | $10.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -11.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.